002630
vs
K
KOSPI 200
002630
Over the past 12 months, Orient Bio Inc has underperformed KOSPI 200, delivering a return of -45% compared to the KOSPI 200's +83% growth.
Stocks Performance
002630 vs KOSPI 200
Performance Gap
002630 vs KOSPI 200
Performance By Year
002630 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Orient Bio Inc
Glance View
ORIENTBIO, Inc. engages in the research and development of biotechnology. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 104 full-time employees. The firm produces and supplies laboratory animals, including mice, rats, guinea pigs, hamsters, specific pathogen free (SPF) rabbits, beagles and others. The company also provides contract research organization (CRO) services, including CRO safety assessment and CRO new drug development services; medical and library equipment, such as barrier systems, and support services such as rodent surgery services, laboratory diagnostics services, transgenic services, genetic testing services and other services. In addition, along with its subsidiaries, the Company provides feeds, reagents, disinfectants, automobile components, power supply equipment, and other machines.